Crescent Biopharma, Inc. (CBIO) Net Income by Year
Crescent Biopharma, Inc. reported $154K in net income in fiscal year 2025. This represents an increase of 306.4% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $96.0M net loss. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters Crescent Biopharma, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CBIO Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY2510-K | FY24DEF 14A | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$96.0M | $154K+306.4% | $38K+2.7% | $37K+100.1% | -$46.7M+26.4% | -$63.4M-24.3% | -$51.0M+11.9% | -$57.9M-19.9% | -$48.3M-45.0% | -$33.3M-4.6% | -$31.8M-149.1% | -$12.8M-14.8% | -$11.1M-4.9% | -$10.6M-390.1% | $3.7M |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
CBIO Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Crescent Biopharma, Inc. financials
Frequently Asked Questions
What was Crescent Biopharma, Inc.'s net income in fiscal year 2025?
Crescent Biopharma, Inc. reported $154K in net income in fiscal year 2025.
How fast is Crescent Biopharma, Inc.'s net income growing?
Crescent Biopharma, Inc. (CBIO) net income rose by 306.4% year over year, from $38K to $154K in fiscal year 2025.
What is Crescent Biopharma, Inc.'s net income over the last twelve months?
Crescent Biopharma, Inc. (CBIO) reported a $96.0M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Crescent Biopharma, Inc.'s net income changed over the years?
Across the 14 fiscal years this page covers, Crescent Biopharma, Inc. (CBIO) net income went from $3.7M in fiscal year 2012 to $154K in fiscal year 2025.
What was Crescent Biopharma, Inc.'s net income in the most recent quarter?
Crescent Biopharma, Inc. (CBIO) reported -$24.8M in net income in Q2 2026. This represents a decrease of 14.0% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Crescent Biopharma, Inc. (CBIO) reported on that line in every period on record.